Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 49.44

-2.5%

1:35 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (2354)	12/20/2000 12:31:16 PM
From: Biomaven	Read Replies (2) of 52153

tuck, Generally my feeling is that the lower tiers lag in a recovery and will only recover after we've seen some strength from the middle and upper tiers. The street generally doesn't seem to distinguish between good science and bad. :( As has been the case much of the year, we are locked to the Nasdaq for reasons that are still unclear to me. Many of the top-tier Nasdaq stocks still look overpriced to me even at their much-reduced levels - paying a huge premium for growth stocks that aren't really growing is still an issue. Many biotechs in contrast are looking reasonably priced to me. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next